UB Paderborn / Katalog / Suche / in CDI

A comparative study of hydrolysis and transglycosylation activities of fungal β-glucosidases

Applied microbiology and biotechnology, 2013, Vol.97 (1), p.159-169

2013

Link zum Volltext

Verfügbarkeit prüfen

Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections

Antimicrobial agents and chemotherapy, 2015-03, Vol.59 (3), p.1435-1440

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of LFF571 in a Hamster Model of Clostridium difficile Infection

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4459-4462

2012

Link zum Volltext

Verfügbarkeit prüfen

Clustering of Hepatotoxins Based on Mechanism of Toxicity Using Gene Expression Profiles

Toxicology and applied pharmacology, 2001-08, Vol.175 (1), p.28-42

2001

Link zum Volltext

Verfügbarkeit prüfen

A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF571 in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5946-5951

2012

Link zum Volltext

Verfügbarkeit prüfen

Digital endpoints for self‐administered home‐based functional assessment in pediatric Friedreich’s ataxia

Annals of clinical and translational neurology, 2021-09, Vol.8 (9), p.1845-1856

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I, Open-Label, Single-Dose Study To Evaluate the Pharmacokinetics and Safety of Telbivudine in Children and Adolescents with Chronic Hepatitis B

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4128-4133

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement : Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial

Annals of internal medicine, 2020-10, Vol.173 (7), p.509

2020

Link zum Volltext

Verfügbarkeit prüfen

Single-Dose Pharmacokinetics, Safety, and Tolerability of Albinterferon Alfa-2b in Subjects with End-Stage Renal Disease on Hemodialysis Compared to Those in Matched Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.473-477

2011

Link zum Volltext

Verfügbarkeit prüfen

mTOR inhibition improves immune function in the elderly

Science translational medicine, 2014-12, Vol.6 (268), p.268ra179

2014

Link zum Volltext

Verfügbarkeit prüfen

A note on the power superiority of the restricted likelihood ratio test

Journal of multivariate analysis, 2012-02, Vol.104 (1), p.1-15

Praestgaard, Jens

2012

Link zum Volltext

Verfügbarkeit prüfen

The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans

Clinical pharmacology in drug development, 2015-01, Vol.4 (1), p.25-32

2015

Link zum Volltext

Verfügbarkeit prüfen

Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial

American journal of respiratory and critical care medicine, 2019-02, Vol.199 (3), p.313-320

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment of sporadic inclusion body myositis with bimagrumab

Neurology, 2014-12, Vol.83 (24), p.2239

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)

Clinical pharmacokinetics, 2023, Vol.62 (1), p.141-155

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort

Journal of cachexia, sarcopenia and muscle, 2020-12, Vol.11 (6), p.1525-1534

2020

Link zum Volltext

Verfügbarkeit prüfen

An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline

Antimicrobial agents and chemotherapy, 2020-10, Vol.64 (11)

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects

Antimicrobial agents and chemotherapy, 2016-12, Vol.60 (12), p.7431-7435

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of bimagrumab on thigh muscle volume and composition in men with casting‐induced atrophy

Journal of cachexia, sarcopenia and muscle, 2017-10, Vol.8 (5), p.727-734

2017

Link zum Volltext

Verfügbarkeit prüfen

Multimodal data collection in Alzheimer’s disease: Participant acceptance of various digital technologies employed in the MEDIA study

Alzheimer's & dementia, 2022-12, Vol.18 (S7), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction for Kovacs et al., "An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline"

Antimicrobial agents and chemotherapy, 2020-12, Vol.65 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial

JAMA network open, 2021-01, Vol.4 (1), p.e2033457

2021

Link zum Volltext

Verfügbarkeit prüfen

Donor hemodynamic profile presages graft survival in donation after cardiac death liver transplantation

Liver transplantation, 2014-02, Vol.20 (2), p.165-172

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A comparative study of hydrolysis and transglycosylation activities of fungal β-glucosidases

Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections

Efficacy of LFF571 in a Hamster Model of Clostridium difficile Infection

Clustering of Hepatotoxins Based on Mechanism of Toxicity Using Gene Expression Profiles

A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression

A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF571 in Healthy Volunteers

Digital endpoints for self‐administered home‐based functional assessment in pediatric Friedreich’s ataxia

Phase I, Open-Label, Single-Dose Study To Evaluate the Pharmacokinetics and Safety of Telbivudine in Children and Adolescents with Chronic Hepatitis B

Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study

Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement : Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial

Single-Dose Pharmacokinetics, Safety, and Tolerability of Albinterferon Alfa-2b in Subjects with End-Stage Renal Disease on Hemodialysis Compared to Those in Matched Healthy Volunteers

mTOR inhibition improves immune function in the elderly

A note on the power superiority of the restricted likelihood ratio test

The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans

Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial

Treatment of sporadic inclusion body myositis with bimagrumab

Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)

Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort

An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline

Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects

Effect of bimagrumab on thigh muscle volume and composition in men with casting‐induced atrophy

Multimodal data collection in Alzheimer’s disease: Participant acceptance of various digital technologies employed in the MEDIA study

Correction for Kovacs et al., "An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline"

Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial

Donor hemodynamic profile presages graft survival in donation after cardiac death liver transplantation

Suchergebnisse filtern